Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000148473 | SCV000051528 | benign | Arrhythmogenic right ventricular cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037294 | SCV000060951 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | p.Val920Gly in exon 15 of DSG2: This variant has been reported in several indivi duals with ARVC or DCM but did not segregate with disease in one family member ( Syrris 2007, Posch 2008, Barahona-Dussault 2010, Christensen 2010). It has been identified in 0.5% (316/66608) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs142841727). This freq uency strongly argues against a disease causing role but is too low to establish this with confidence. |
Eurofins Ntd Llc |
RCV000037294 | SCV000226263 | benign | not specified | 2015-05-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037294 | SCV000233469 | benign | not specified | 2015-05-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genomic Diagnostic Laboratory, |
RCV000148473 | SCV000257908 | benign | Arrhythmogenic right ventricular cardiomyopathy | 2015-06-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000755252 | SCV000287237 | benign | Arrhythmogenic right ventricular dysplasia 10 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000245262 | SCV000318981 | benign | Cardiovascular phenotype | 2017-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001701728 | SCV000603385 | benign | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000037294 | SCV000747997 | benign | not specified | 2017-02-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776064 | SCV000910712 | benign | Cardiomyopathy | 2018-04-08 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852745 | SCV000995462 | benign | Arrhythmogenic right ventricular cardiomyopathy; Cardiomyopathy | 2018-05-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000755252 | SCV001287045 | likely benign | Arrhythmogenic right ventricular dysplasia 10 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV000776064 | SCV002043142 | benign | Cardiomyopathy | 2020-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001701728 | SCV002563458 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | DSG2: BP4, BS2 |
Breakthrough Genomics, |
RCV001701728 | SCV005215252 | likely benign | not provided | criteria provided, single submitter | not provided | ||
CSER _CC_NCGL, |
RCV000148473 | SCV000190174 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2014-06-01 | no assertion criteria provided | research | |
Stanford Center for Inherited Cardiovascular Disease, |
RCV000037294 | SCV000280084 | uncertain significance | not specified | 2015-06-24 | no assertion criteria provided | clinical testing | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. We consider this variant to be of uncertain significance, likely benign, given it is present in multiple control samples and that it failed to segregate with disease in one family. This variant has been reported in 6 unrelated cases with either ARVC or DCM and as many as 6 total cases. Syrris et al (2006) initially identified the variant in a 17 yo male who had a sudden cardiac arrest, a left ventricular variant of ARVC was confirmed on autopsy. The proband’s father who had a positive phenotype on MRI and an abnormal signal average ECG was found to be genotype positive for the variant. Posch et al (2008) identified the variant in two families with dilated cardiomyopathy (note they refer to the variant as p.Val919Gly due to a numbering difference). However they report that the variant did not segregate with the phenotype in one family. In that family five affected relatives had the variant but one affected relative did not, indicating that it is likely not the primary causative variant of their disease. Christensen et al (2010) also reported the variant in 1 case that was clinically borderline for ARVC. Quarta et al (2011) found p.Val920Gly in 2 out of 100 families with ARVC. This is a conservative amino acid change with a nonpolar Valine replaced by a nonpolar Glyceine. SIFT predicts the amino acid change to be tolerated while PolyPhen predicts it to be probably damaging to the resulting protein. A variant in a nearby codon (p.Pro925Ser) has been reported in association with disease (University Medical Center Groningen ARVD/C Genetic Variants Database). Syrris et al (2006) reported that the variant was absent in 200 presumably healthy controls. Posch et al (2008) identified p.Val920Gly in 2 out of 432 presumably healthy control individuals. Christensen et al (2010) reported that the variant was present in 3 out of 650 individuals from a control population. Cox et al (2011) reported that the variant was absent in 200 controls. The variant is listed in dbSNP (rs142841727) with frequency data from the ClinSeq project, where it was seen in 8 of 660 individuals. It is listed in 1000Genomes, but only in reference to the dbSNP entry (as of April 17th, 2013). Additionally the variant was found in 41/4135 Caucasians and 6/1948 African American individuals in the NHLBI Exome Sequencing Project dataset (as of April 17th, 2013). |
Diagnostic Laboratory, |
RCV000037294 | SCV001740980 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701728 | SCV001930813 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037294 | SCV001970597 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037294 | SCV001979185 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003914935 | SCV004728201 | benign | DSG2-related disorder | 2019-09-30 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |